Published in World J Gastroenterol on October 21, 2013
Haemostatic and fibrinolytic changes in obese subjects undergoing bariatric surgery: the effect of different surgical procedures. Blood Transfus (2014) 0.77
Family history of Alzheimer's disease limits improvement in cognitive function after bariatric surgery. SAGE Open Med (2014) 0.77
Laparoscopic mini-gastric bypass in patients age 60 and older. Surg Endosc (2015) 0.77
Efficacy of Laparoscopic Mini Gastric Bypass for Obesity and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Gastroenterol Res Pract (2015) 0.76
Laparoscopic sleeve gastrectomy for the treatment of diabetes mellitus type 2 patients-single center early experience. Gland Surg (2016) 0.75
Bariatric surgery is not contraindicated in obese patients suffering from glycogen storage disease type IXa. A case report with follow-up at three years. Int J Surg Case Rep (2014) 0.75
Gastrointestinal dopamine as an anti-incretin and its possible role in bypass surgery as therapy for type 2 diabetes with associated obesity. Minerva Endocrinol (2015) 0.75
An early onset of acute renal failure in a young woman with obesity and infertility who underwent gastric balloon positioning. A case report. G Chir (2014) 0.75
Type 2 diabetes remission following gastric bypass: does diarem stand the test of time? Surg Endosc (2016) 0.75
Laparoscopic One-Anastomosis Gastric Bypass: Technique, Results, and Long-Term Follow-Up in 1200 Patients. Obes Surg (2016) 0.75
Metabolic consequences of the incorporation of a Roux limb in an omega loop (mini) gastric bypass: evaluation by a glucose tolerance test at mid-term follow-up. Surg Endosc (2015) 0.75
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care (2004) 75.82
The World Health Report 2006: working together for health. Educ Health (Abingdon) (2006) 39.73
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA (2003) 25.44
Bariatric surgery: a systematic review and meta-analysis. JAMA (2004) 23.34
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer (2004) 16.69
The continuing epidemics of obesity and diabetes in the United States. JAMA (2001) 14.84
Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med (2001) 14.48
Abdominal obesity and metabolic syndrome. Nature (2006) 14.20
Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med (2009) 13.91
Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care (2006) 12.14
Obesity and diabetes in the developing world--a growing challenge. N Engl J Med (2007) 10.54
Diabetes trends in the U.S.: 1990-1998. Diabetes Care (2000) 7.05
Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med (2005) 6.88
The evolving diabetes burden in the United States. Ann Intern Med (2004) 6.36
Diabetes in Asia. Lancet (2009) 5.96
Trends in bariatric surgical procedures. JAMA (2005) 5.67
Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg (2006) 4.30
The role of gut hormones in glucose homeostasis. J Clin Invest (2007) 3.36
Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg (2004) 3.23
Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol (2006) 3.11
Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis (2007) 3.01
Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc (2006) 2.51
Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg (2011) 2.33
Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab (2001) 2.13
The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg (2001) 2.05
Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg (2005) 1.96
Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc (2009) 1.69
Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery. Int J Obes (Lond) (2009) 1.65
Revisional surgery for laparoscopic minigastric bypass. Surg Obes Relat Dis (2010) 1.49
Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence? Obes Surg (2008) 1.45
Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI>35 and <35 kg/m2. J Gastrointest Surg (2007) 1.36
Laparoscopic Roux-en-Y vs. mini-gastric bypass for the treatment of morbid obesity: a 10-year experience. Obes Surg (2012) 1.31
Continued excellent results with the mini-gastric bypass: six-year study in 2,410 patients. Obes Surg (2005) 1.17
Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery. Surg Obes Relat Dis (2007) 1.17
Effects of obesity surgery on the metabolic syndrome. Arch Surg (2004) 1.15
Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects. Surg Endosc (2012) 1.11
Role of bariatric-metabolic surgery in the treatment of obese type 2 diabetes with body mass index <35 kg/m2: a literature review. Diabetes Technol Ther (2011) 1.08
The potential role of intragastric balloon in the treatment of obese-related infertility: personal experience. Obes Surg (2011) 1.02
Late micronutrient deficiency and neurological dysfunction after laparoscopic sleeve gastrectomy: a case report. Eur J Clin Nutr (2012) 1.01
Effect of bariatric surgery on obesity-related infertility. Surg Obes Relat Dis (2011) 1.00
Abnormally high prevalence of major components of the metabolic syndrome in subjects with early-onset idiopathic venous thromboembolism. Thromb Res (2011) 0.95
Which criteria should be used to define type 2 diabetes remission after bariatric surgery? BMC Surg (2013) 0.92
Short-term results of laparoscopic mini-gastric bypass. Obes Surg (2005) 0.90
Laparoscopic mini-gastric bypass for type 2 diabetes: the preliminary report. World J Surg (2011) 0.90
2004 ASBS Consensus Conference on Surgery for Severe Obesity. Surg Obes Relat Dis (2006) 0.89
Safety and efficacy of barbed suture for gastrointestinal suture: a prospective and randomized study on obese patients undergoing gastric bypass. J Laparoendosc Adv Surg Tech A (2013) 0.87
Female reproductive issues following bariatric surgery. Obstet Gynecol Surv (2007) 0.86
Obesity is a surgical disease: overview of obesity and bariatric surgery. ANZ J Surg (2004) 0.85
Perioperative handling of antiplatelet drugs. A critical appraisal. Curr Drug Targets (2013) 0.85
Preventing surgical site infections after bariatric surgery: value of perioperative antibiotic regimens. Expert Rev Pharmacoecon Outcomes Res (2010) 0.85
Primary results of laparoscopic mini-gastric bypass in a French obesity-surgery specialized university hospital. Obes Surg (2008) 0.82
Treating type 2 diabetes mellitus with sleeve gastrectomy in obese patients. Obesity (Silver Spring) (2010) 0.81
Laparoscopic mini-gastric bypass: short-term single-institute experience. Updates Surg (2011) 0.80
Clinical efficacy of laparoscopic sleeve gastrectomy vs laparoscopic gastric bypass in obese type 2 diabetic patients: a retrospective comparison. Obes Surg (2012) 0.80
Bariatric surgery and T2DM improvement mechanisms: a mathematical model. Theor Biol Med Model (2012) 0.78
Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell (2007) 10.13
Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell (2008) 6.26
Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol (2007) 5.50
FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest (2003) 3.60
The conditional inactivation of the beta-catenin gene in endothelial cells causes a defective vascular pattern and increased vascular fragility. J Cell Biol (2003) 2.77
The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development (2002) 2.50
Biglycan deficiency causes spontaneous aortic dissection and rupture in mice. Circulation (2007) 1.98
Mesoangioblasts--vascular progenitors for extravascular mesodermal tissues. Curr Opin Genet Dev (2003) 1.80
Early psoriatic arthritis: the clinical spectrum. J Rheumatol (2007) 1.79
Natural history and treatment of fibrous dysplasia of bone: a multicenter clinicopathologic study promoted by the European Pediatric Orthopaedic Society. J Pediatr Orthop B (2003) 1.78
Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth. Hum Mol Genet (2007) 1.56
The metalloproteinase MT1-MMP is required for normal development and maintenance of osteocyte processes in bone. J Cell Sci (2004) 1.46
MT1-MMP: a tethered collagenase. J Cell Physiol (2004) 1.45
Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome. J Bone Miner Res (2003) 1.39
MT1-MMP-dependent, apoptotic remodeling of unmineralized cartilage: a critical process in skeletal growth. J Cell Biol (2003) 1.36
Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. World J Gastroenterol (2010) 1.35
Osteomalacic and hyperparathyroid changes in fibrous dysplasia of bone: core biopsy studies and clinical correlations. J Bone Miner Res (2003) 1.28
Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome. J Clin Endocrinol Metab (2002) 1.28
Enumeration of the colony-forming units-fibroblast from mouse and human bone marrow in normal and pathological conditions. Stem Cell Res (2008) 1.27
Fibrous dysplasia as a stem cell disease. J Bone Miner Res (2006) 1.25
Laparoscopic adrenalectomy, a safe procedure for pheochromocytoma. A retrospective review of clinical series. Int J Surg (2012) 1.25
A randomized, double blind, placebo-controlled trial of alendronate treatment for fibrous dysplasia of bone. J Clin Endocrinol Metab (2014) 1.20
Drug-induced liver injury: is it somehow foreseeable? World J Gastroenterol (2009) 1.18
Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease. World J Gastroenterol (2012) 1.17
Thyroid nodules and related symptoms are stably controlled two years after radiofrequency thermal ablation. Thyroid (2009) 1.16
Medical therapy for clinically non-functioning pituitary adenomas. Endocr Relat Cancer (2008) 1.13
Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively? J Inflamm (Lond) (2009) 1.13
Age-dependent demise of GNAS-mutated skeletal stem cells and "normalization" of fibrous dysplasia of bone. J Bone Miner Res (2008) 1.12
An instrument to measure skeletal burden and predict functional outcome in fibrous dysplasia of bone. J Bone Miner Res (2004) 1.11
Are hepatic steatosis and carotid intima media thickness associated in obese patients with normal or slightly elevated gamma-glutamyl-transferase? J Transl Med (2012) 1.10
Differences of myocardial systolic deformation and correlates of diastolic function in competitive rowers and young hypertensives: a speckle-tracking echocardiography study. J Am Soc Echocardiogr (2010) 1.09
Transfer, analysis, and reversion of the fibrous dysplasia cellular phenotype in human skeletal progenitors. J Bone Miner Res (2010) 1.08
The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. J Clin Endocrinol Metab (2004) 1.07
Treatment of hemophilia: a review of current advances and ongoing issues. J Blood Med (2010) 1.07
Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers. Ann Rheum Dis (2013) 1.07
Skeletal progenitors and the GNAS gene: fibrous dysplasia of bone read through stem cells. J Mol Endocrinol (2010) 1.06
Laparocopic ventral hernia repair with primary transparietal closure of the hernial defect. BMC Surg (2012) 1.06
Obesity and the prediction of minimal disease activity: a prospective study in psoriatic arthritis. Arthritis Care Res (Hoboken) (2013) 1.05
Reconstruction of extensive long bone defects in sheep using resorbable bioceramics based on silicon stabilized tricalcium phosphate. Tissue Eng (2006) 1.03
TGFbeta/BMP activate the smooth muscle/bone differentiation programs in mesoangioblasts. J Cell Sci (2004) 1.03
Formation of a chondro-osseous rudiment in micromass cultures of human bone-marrow stromal cells. J Cell Sci (2003) 1.02
The potential role of intragastric balloon in the treatment of obese-related infertility: personal experience. Obes Surg (2011) 1.02
Nail and distal interphalangeal joint in psoriatic arthritis. J Rheumatol (2006) 1.00
Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects. Eur J Endocrinol (2008) 1.00
Effect of bariatric surgery on obesity-related infertility. Surg Obes Relat Dis (2011) 1.00
Medical treatment of prolactinomas. Nat Rev Endocrinol (2011) 1.00
Depletion of cartilage collagen fibrils in mice carrying a dominant negative Col2a1 transgene affects chondrocyte differentiation. Am J Physiol Cell Physiol (2003) 0.99
Effectiveness of a drain in surgical treatment of sacrococcygeal pilonidal disease. Results of a randomized and controlled clinical trial on 803 consecutive patients. Int J Colorectal Dis (2011) 0.98
Predictors of early minimal disease activity in patients with psoriatic arthritis treated with tumor necrosis factor-α blockers. J Rheumatol (2012) 0.98
Disseminated intravascular coagulation in hematologic malignancies. Semin Thromb Hemost (2010) 0.98
Bisphenol A in polycystic ovary syndrome and its association with liver-spleen axis. Clin Endocrinol (Oxf) (2013) 0.98
Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management. Rheumatology (Oxford) (2012) 0.96
The role of stem cells in fibrous dysplasia of bone and the Mccune-Albright syndrome. Pediatr Endocrinol Rev (2007) 0.96
Endothelial and smooth muscle cells from abdominal aortic aneurysm have increased oxidative stress and telomere attrition. PLoS One (2012) 0.96
In vivo osteoprogenitor potency of human stromal cells from different tissues does not correlate with expression of POU5F1 or its pseudogenes. Stem Cells (2008) 0.96
Bioluminescence imaging of calvarial bone repair using bone marrow and adipose tissue-derived mesenchymal stem cells. Biomaterials (2007) 0.95
Bone marrow stromal cell assays: in vitro and in vivo. Methods Mol Biol (2014) 0.95
Congenital unilateral posteromedial bowing of the tibia and fibula: insights regarding pathogenesis from prenatal pathology. A case report. J Bone Joint Surg Am (2005) 0.95
Human bone marrow mesenchymal stem cells: a systematic reappraisal via the genostem experience. Stem Cell Rev (2011) 0.95
The use of adult stem cells in rebuilding the human face. J Am Dent Assoc (2006) 0.94
Intracorporeal versus extracorporeal anastomosis. Results from a multicentre comparative study on 512 right-sided colorectal cancers. Surg Endosc (2014) 0.94
The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: results of a pilot randomised 6-month trial with methotrexate. Clin Rheumatol (2007) 0.94
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study. J Clin Endocrinol Metab (2005) 0.93
Management of high-grade retroperitoneal liposarcomas: personal experience. Updates Surg (2011) 0.93
Inflammation may modulate IL-6 and C-reactive protein gene expression in the adipose tissue: the role of IL-6 cell membrane receptor. Am J Physiol Endocrinol Metab (2007) 0.93
A reappraisal of diagnosing GH deficiency in adults: role of gender, age, waist circumference, and body mass index. J Clin Endocrinol Metab (2009) 0.93
Laparoscopic reinforced sleeve gastrectomy: early results and complications. Obes Surg (2011) 0.93
Adrenal incidentalomas in the laparoscopic era and the role of correct surgical indications: observations from 255 consecutive adrenalectomies in an Italian series. Can J Surg (2009) 0.93
A novel technique based on a PNA hybridization probe and FRET principle for quantification of mutant genotype in fibrous dysplasia/McCune-Albright syndrome. Nucleic Acids Res (2004) 0.93
Incidentally detected giant oncocytoma arising in retroperitoneal heterotopic adrenal tissue. Arch Pathol Lab Med (2002) 0.92
Hepatic steatosis and disease activity in subjects with psoriatic arthritis receiving tumor necrosis factor-α blockers. J Rheumatol (2012) 0.91
Effects of treatment with metformin on TSH levels: a meta-analysis of literature studies. J Clin Endocrinol Metab (2013) 0.91
Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: a review of the literature. Semin Thromb Hemost (2011) 0.91
Teriparatide vs. alendronate as a treatment for osteoporosis: changes in biochemical markers of bone turnover, BMD and quality of life. Med Sci Monit (2011) 0.91
Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery. Cochrane Database Syst Rev (2015) 0.90
On the role of MT1-MMP, a matrix metalloproteinase essential to collagen remodeling, in murine molar eruption and root growth. Eur J Oral Sci (2002) 0.90
Troponin I and right ventricular dysfunction for risk assessment in patients with nonmassive pulmonary embolism in the Emergency Department in combination with clinically based risk score. Intern Emerg Med (2008) 0.90
Monostotic fibrous dysplasia of the proximal femur and liposclerosing myxofibrous tumor: which one is which? J Bone Miner Res (2006) 0.90
Filling the gap between science & clinical practice: prevention of stroke recurrence. Thromb Res (2011) 0.90
Regulation: Sell help not hope. Nature (2014) 0.90
Hepatic steatosis, carotid plaques and achieving MDA in psoriatic arthritis patients starting TNF-α blockers treatment: a prospective study. Arthritis Res Ther (2012) 0.90
Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2003) 0.90
Tissue factor and atherosclerosis: not only vessel wall-derived TF, but also platelet-associated TF. Thromb Res (2011) 0.90
Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease. World J Gastroenterol (2011) 0.89
Computed tomography findings of pneumatosis and portomesenteric venous gas in acute bowel ischemia. World J Gastroenterol (2013) 0.89
Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study. Am J Hematol (2012) 0.89
Homocysteine and arterial thrombosis: Challenge and opportunity. Thromb Haemost (2010) 0.89
The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis. J Clin Endocrinol Metab (2006) 0.89